Emcure Pharmaceuticals Ltd (EMCURE) — Free Cash Flow Generation Index
Emcure Pharmaceuticals Ltd (EMCURE) has a Free Cash Flow Generation Index of 0.50x as of September 2025. Free cash flow of Rs1.27 Billion represents 0% of operating cash flow (Rs2.56 Billion). Explore Emcure Pharmaceuticals Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Emcure Pharmaceuticals Ltd Free Cash Flow Generation Index (2022–2026)
Historical FCF Generation Index trend for Emcure Pharmaceuticals Ltd across 5 annual periods. For the full cash flow conversion analysis, see Emcure Pharmaceuticals Ltd cash conversion from operations.
Annual Free Cash Flow Generation for Emcure Pharmaceuticals Ltd (2022–2026)
Year-by-year Free Cash Flow Generation Index for Emcure Pharmaceuticals Ltd. Check EMCURE total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.58x | Rs4.90 Billion | Rs8.51 Billion | Rs3.61 Billion | ▲ +10.3% |
| 2025 | 0.52x | Rs4.45 Billion | Rs8.52 Billion | Rs4.07 Billion | ▼ -27.5% |
| 2024 | 0.72x | Rs7.90 Billion | Rs10.97 Billion | Rs3.07 Billion | ▲ +56.6% |
| 2023 | 0.46x | Rs3.43 Billion | Rs7.47 Billion | Rs4.03 Billion | ▼ -4.8% |
| 2022 | 0.48x | Rs3.71 Billion | Rs7.68 Billion | Rs3.97 Billion | — |